Goodscend Pharm. Sci. & Tech.

Goodscend Pharmaceutical Science & Technology is a clinical-stage biopharmaceutical company headquartered in Guangzhou, China, dedicated to the development of advanced inhalation therapies. The company leverages its proprietary technology platforms in dry powder inhalers (DPI), soft mist inhalers (SMI), and nebulized formulations to treat respiratory and systemic diseases. Its pipeline includes high-entry-barrier generic and innovative drugs targeting conditions such as asthma, chronic obstructive pulmonary disease (COPD), and pulmonary arterial hypertension. Goodscend integrates formulation development with device design to ensure precise pulmonary delivery and improved patient outcomes. Led by a team of industry veterans, the company has secured significant venture capital funding to advance its clinical programs toward commercialization.